Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Operating Expenses | 9,455 | 3,833 | 882 | 0 | 0 |
| Operating Income | -9,455 | -3,833 | -882 | N/A | N/A |
| Interest Expense | 3 | 26 | 29 | 0 | 0 |
| Other Income | 0 | -18 | -6,482 | 0 | 0 |
| Pre-tax Income | -9,458 | -3,877 | -7,392 | 0 | 0 |
| Net Income Continuous | -9,458 | -3,877 | -7,392 | N/A | N/A |
| Net Income | $-9,458 | $-3,877 | $-7,392 | $N/A | $N/A |
| EPS Basic Total Ops | -51,325.66 | -25,212.61 | -63,031.51 | N/A | N/A |
| EPS Basic Continuous Ops | -51,247.70 | -25,580.57 | -63,324.49 | N/A | N/A |
| EPS Diluted Total Ops | -51,325.66 | -25,212.61 | -63,031.51 | N/A | N/A |
| EPS Diluted Continuous Ops | -51,247.70 | -25,580.57 | -63,324.49 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -51,325.66 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-9,444 | $-3,813 | $-864 | $N/A | $N/A |